Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)

Yoo, C.; Kim, H-D.; Chon, H. J.; Sym, S. J.; Kim, M.; Kang, J. H.; Ryoo, B-Y.; Lee, C-K.; Hong, J.; Ryu, H.; Bae, W. K.; Kim, H.; Kim, H.; Kim, J. W.; Kim, T-Y.

doi:10.1016/j.annonc.2024.10.149

상세 보기

Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)

Yoo, C.;
Kim, H-D.;
Chon, H. J.;
Sym, S. J.;
Kim, M.;
... Kang, J. H.;
외 9명

Citations

WEB OF SCIENCE

6

Citations

SCOPUS

0

제목: Multicenter phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (KCSG HB23-04)

저자: Yoo, C.; Kim, H-D.; Chon, H. J.; Sym, S. J.; Kim, M.; Kang, J. H.; Ryoo, B-Y.; Lee, C-K.; Hong, J.; Ryu, H.; Bae, W. K.; Kim, H.; Kim, H.; Kim, J. W.; Kim, T-Y.

DOI: 10.1016/j.annonc.2024.10.149

발행일: 2024-12

유형: Meeting Abstract

저널명: Annals of Oncology

권: 35

페이지: S1450 ~ S1450

ScholarWorks@경상국립대학교

상세 보기